Bio-Ethics Drugs and Formulation Limited
About Bio-Ethics Drugs and Formulation Limited
Data last updated:
Bio-Ethics Drugs and Formulation Limited was a public limited company based in Cuttack, Odisha, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 16 March 1995.
The company was registered with the Registrar of Companies (ROC), Cuttack, under CIN U24231OR1995PLC003917.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was led by director Dhirendra Nath Dalai.
Its last annual general meeting (AGM) was held on 30 September 2008, and its latest financial statements are for the year ended 31 March 2008. The registered office was at Shreeram Bhawanmadhupatna Madhupatna, Cuttack, Odisha, India – 753010.
Company details
Contact details
Bio-Ethics Drugs and Formulation Limited's registered office is in Cuttack, Odisha.
- Registered AddressShreeram Bhawanmadhupatna Madhupatna, Cuttack, Odisha, India – 753010
- IndustryChemicals, Other Chemical Product, Manufacturing, Pharmaceutical Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bio-Ethics Drugs and Formulation Limited
FY 2008 filings availableFinancial Statement Summary
| Metrics | FY 2007-08 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2007-08 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bio-Ethics Drugs and Formulation Limited, buy the company report.
Board of directors of Bio-Ethics Drugs and Formulation Limited
Bio-Ethics Drugs and Formulation has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhirendra Nath Dalai | Director | 11 Feb 2003 | 23 Years 8 Months | As last reported |
Legal cases
No court or tribunal cases involving Bio-Ethics Drugs and Formulation Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bio-Ethics Drugs and Formulation Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bio-Ethics Drugs and Formulation Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bio-Ethics Drugs and Formulation Limited has 1 board change on record since 2003: 1 appointment. The latest: Dhirendra Nath Dalai was appointed as Director on 11 Feb 2003.
Frequently asked questions
Bio-Ethics Drugs and Formulation has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bio-Ethics Drugs and Formulation was a public limited company based in Cuttack, Odisha, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 16 March 1995 and is registered under CIN U24231OR1995PLC003917. The company has been struck off by the Registrar of Companies and is no longer operational.
Bio-Ethics Drugs and Formulation had 1 director:
- Dhirendra Nath Dalai - Director
The CIN (Corporate Identification Number) of Bio-Ethics Drugs and Formulation is U24231OR1995PLC003917. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bio-Ethics Drugs and Formulation is at Shreeram Bhawanmadhupatna Madhupatna, Cuttack, Odisha, India – 753010.
Bio-Ethics Drugs and Formulation was incorporated on 16 March 1995. It is registered with the Registrar of Companies, Cuttack.
The latest financial statements of Bio-Ethics Drugs and Formulation on record with the MCA are for the year ended 31 March 2008. Its last annual general meeting was held on 30 September 2008. Year-wise statements from 2015 are in the company report.
Bio-Ethics Drugs and Formulation operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Dhirendra Nath Dalai was appointed as Director on 11 Feb 2003.
Bio-Ethics Drugs and Formulation can be reached at its registered office: Shreeram Bhawanmadhupatna Madhupatna, Cuttack, Odisha, India – 753010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
